| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Radiation Oncology Journal Search > Browse Articles > Search



Stereotactic radiosurgery for limited brain metastasis using three different techniques: helical tomotherapy, volumetric modulated arc therapy, and cone-based LINAC radiosurgery
Bongkot Jia-Mahasap, Chakri Madla, Patumrat Sripan, Imjai Chitapanarux, Ekkasit Tharavichitkul, Somvilai Chakrabandhu, Pitchayaponne Klunklin, Wimrak Onchan
Radiat Oncol J. 2022;40(4):232-241.   Published online 2022 Dec 26     DOI: https://doi.org/10.3857/roj.2022.00136
                              Supplementary      
roj-2022-00136f1.jpgroj-2022-00136f2.jpgroj-2022-00136f3.jpgt2-roj-2022-00136.png
Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates
Nalee Kim, Yong Bae Kim
Radiat Oncol J. 2022;40(4):216-224.   Published online 2022 Dec 26     DOI: https://doi.org/10.3857/roj.2022.00577
                              
roj-2022-00577f1.jpgroj-2022-00577f2.jpg
A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
Sergey Nikolaevich Novikov, Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev
Radiat Oncol J. 2022;40(3):200-207.   Published online 2022 Sep 30     DOI: https://doi.org/10.3857/roj.2022.00339
                              
roj-2022-00339f1.jpgroj-2022-00339f2.jpgt2-roj-2022-00339.pngt3-roj-2022-00339.png
Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach
Radiat Oncol J. 2022;40(3):192-199.   Published online 2022 Sep 27     DOI: https://doi.org/10.3857/roj.2022.00101
                              
roj-2022-00101f1.jpg
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease
Rahul N. Prasad, Peter J. Kobalka, Haley K. Perlow, Daniel M. Prevedello, Dukagjin M. Blakaj, Raju R. Raval, Joshua D. Palmer
Radiat Oncol J. 2022;40(2):162-168.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01074
                              
roj-2021-01074f1.jpgroj-2021-01074f2.jpgroj-2021-01074f3.jpgroj-2021-01074f4.jpg
Clinical Investigations
Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
Christos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis
Radiat Oncol J. 2022;40(2):151-161.   Published online 2022 Jun 20     DOI: https://doi.org/10.3857/roj.2021.01032
                              
roj-2021-01032f1.jpgroj-2021-01032f2.jpgroj-2021-01032f3.jpg
Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
Chawalit Lertbutsayanukul, Manida Pitak, Chonnipa Nantavithya
Radiat Oncol J. 2022;40(2):141-150.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.00927
                              Supplementary         Cited By 1
roj-2021-00927f1.jpgroj-2021-00927f2.jpg
Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Budhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Singh Oinam
Radiat Oncol J. 2022;40(2):127-140.   Published online 2022 Jun 20     DOI: https://doi.org/10.3857/roj.2021.01053
                              
roj-2021-01053f1.jpgroj-2021-01053f2.jpgroj-2021-01053f3.jpgroj-2021-01053f4.jpg
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Joo Ho Lee, Seong Keun Kwon, Eun-Jae Chung, Hong-Gyun Wu
Radiat Oncol J. 2022;40(2):120-126.   Published online 2022 May 17     DOI: https://doi.org/10.3857/roj.2021.01025
                              
roj-2021-01025f1.jpgroj-2021-01025f2.jpgt2-roj-2021-01025.png
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2022;40(2):111-119.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01060
                              Supplementary         Cited By 1
roj-2021-01060f1.jpgroj-2021-01060f2.jpgt2-roj-2021-01060.png
Biology contributions
Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy
Yeeun Kim, Changhoon Choi, Jee Hyun Park, Won-Gyun Ahn, Sung-Won Shin, Shin-Yeong Kim, Jae Myoung Noh
Radiat Oncol J. 2022;40(1):53-65.   Published online 2022 Feb 23     DOI: https://doi.org/10.3857/roj.2021.00885
                                 Cited By 2
roj-2021-00885f1.jpgroj-2021-00885f2.jpgroj-2021-00885f3.jpgroj-2021-00885f4.jpgroj-2021-00885f5.jpg
Clinical Investigations
Long-term outcomes of low-dose radiotherapy in Kasabach-Merritt syndrome
Dowook Kim, Jung Yoon Choi, Kyung Taek Hong, Hyoung Jin Kang, Il Han Kim, Joo Ho Lee
Radiat Oncol J. 2022;40(1):45-52.   Published online 2022 Mar 22     DOI: https://doi.org/10.3857/roj.2021.00983
                                 Cited By 1
roj-2021-00983f1.jpgroj-2021-00983f2.jpgroj-2021-00983f3.jpg
PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J. 2022;40(1):20-28.   Published online 2022 Mar 25     DOI: https://doi.org/10.3857/roj.2021.00934
                                 Cited By 1
roj-2021-00934f1.jpgroj-2021-00934f2.jpgroj-2021-00934f3.jpgroj-2021-00934f4.jpg
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Ding Ding, Amy Hacker-Prietz, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2021;39(4):304-314.   Published online 2021 Dec 17     DOI: https://doi.org/10.3857/roj.2021.00815
                              Supplementary         Cited By 2
roj-2021-00815f1.jpgroj-2021-00815f2.jpg
Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients
Alimohammad Bananzadeh, Ali Akbar Hafezi, NamPhong Nguyen, Shapour Omidvari, Ahmad Mosalaei, Niloofar Ahmadloo, Mansour Ansari, Mohammad Mohammadianpanah
Radiat Oncol J. 2021;39(4):270-278.   Published online 2021 Oct 26     DOI: https://doi.org/10.3857/roj.2021.00654
                                 Cited By 2
roj-2021-00654f1.jpgroj-2021-00654f2.jpg
Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
Kazuya Takeda, Haruo Matsushita, Rei Umezawa, Takaya Yamamoto, Yojiro Ishikawa, Noriyoshi Takahashi, Yu Suzuki, Keiichi Jingu
Radiat Oncol J. 2021;39(4):265-269.   Published online 2021 Sep 3     DOI: https://doi.org/10.3857/roj.2021.00325
                              
roj-2021-00325f1.jpgroj-2021-00325f2.jpg
Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases
Ben Man Fei Cheung, Kin Sang Lau, Victor Ho Fun Lee, To Wai Leung, Feng-Ming Spring Kong, Mai Yee Luk, Kwok Keung Yuen
Radiat Oncol J. 2021;39(4):254-264.   Published online 2021 Oct 26     DOI: https://doi.org/10.3857/roj.2021.00311
                              Supplementary         Cited By 1
roj-2021-00311f1.jpgroj-2021-00311f2.jpgroj-2021-00311f3.jpg
Abscopal effect in the radio and immunotherapy
Alina M. Pevzner, Matvey M. Tsyganov, Marina K. Ibragimova, Nikolai V. Litvyakov
Radiat Oncol J. 2021;39(4):247-253.   Published online 2021 Oct 25     DOI: https://doi.org/10.3857/roj.2021.00115
                                 Cited By 6
roj-2021-00115f1.jpg
Clinical Investigations
Early toxicities of ultrahypofractionated stereotactic body radiotherapy for intermediate risk localized prostate cancer using cone-beam computed tomography and real-time three-dimensional transperineal ultrasound monitoring
Eric Ka-Chai Lee, Ronnie Wing-Kin Leung, Hollis Siu-Leung Luk, Barry Bar-Wai Wo
Radiat Oncol J. 2021;39(3):239-245.   Published online 2021 Sep 28     DOI: https://doi.org/10.3857/roj.2020.00969
                              Supplementary      
roj-2020-00969f1.jpgroj-2020-00969f2.jpgroj-2020-00969f3.jpg
Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
Seok-Joo Chun, Jin Ho Kim, Ja Hyeon Ku, Cheol Kwak, Eun Sik Lee, Suzy Kim
Radiat Oncol J. 2021;39(3):231-238.   Published online 2021 Sep 9     DOI: https://doi.org/10.3857/roj.2021.00486
                                 Cited By 1
roj-2021-00486f1.jpgroj-2021-00486f2.jpgroj-2021-00486f3.jpg
Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature
Garrett Lee Jensen, Megan Ann Mezera, Salman Hasan, Kendall Pye Hammonds, Gregory Peter Swanson, Moataz Nier El-Ghamry
Radiat Oncol J. 2021;39(3):219-230.   Published online 2021 Jul 13     DOI: https://doi.org/10.3857/roj.2020.00948
                              
roj-2020-00948f1.jpgroj-2020-00948f2.jpgroj-2020-00948f3.jpgt1-roj-2020-00948.png
Safety and efficacy of 10-fraction hypofractionated radiation therapy for non-small cell lung cancer
Ye Jin Yoo, Su Ssan Kim, Si Yeol Song, Jong Hoon Kim, Seung Do Ahn, Sang-wook Lee, Sang Min Yoon, Young Seok Kim, Jin-hong Park, Jinhong Jung, Eun Kyung Choi
Radiat Oncol J. 2021;39(3):202-209.   Published online 2021 Sep 9     DOI: https://doi.org/10.3857/roj.2021.00416
                              
roj-2021-00416f1.jpgroj-2021-00416f2.jpgroj-2021-00416f3.jpgt1-roj-2021-00416.png
Intrathyroidal parathyroid carcinoma: a case report and literature review
Kenza Benali, Jihan Aarab, Houda Benmessaoud, Abdelati Nourreddine, Sanaa El Majjaoui, Hanan El Kacemi, Tayeb Kebdani, Noureddine Benjaafar
Radiat Oncol J. 2021;39(2):145-151.   Published online 2021 Mar 24     DOI: https://doi.org/10.3857/roj.2020.01060
                                 Cited By 2
roj-2020-01060f1.jpgroj-2020-01060f2.jpgroj-2020-01060f3.jpgt1-roj-2020-01060.png
Abscopal effect after palliative five-fraction radiation therapy on bone and lymph node metastases from luminal B breast cancer: a case report and clinical implications for palliative radiation therapy
Tae Hyung Kim, Jee Suk Chang
Radiat Oncol J. 2021;39(2):139-144.   Published online 2021 Apr 16     DOI: https://doi.org/10.3857/roj.2020.00990
                                 Cited By 1
roj-2020-00990f1.jpgroj-2020-00990f2.jpgroj-2020-00990f3.jpgroj-2020-00990f4.jpg
Clinical Investigations
Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
Jason Liu, Colton Ladbury, Arya Amini, Scott Glaser, Jonathan Kessler, Aram Lee, Yi-Jen Chen
Radiat Oncol J. 2021;39(2):113-121.   Published online 2021 Jun 18     DOI: https://doi.org/10.3857/roj.2021.00213
                              
roj-2021-00213f1.jpgroj-2021-00213f2.jpgroj-2021-00213f3.jpgroj-2021-00213f4.jpg
Clinical investigations
Risk of second cancer among young prostate cancer survivors
Hong Zhang, Andrew Yu, Andrea Baran, Edward Messing
Radiat Oncol J. 2021;39(2):91-98.   Published online 2021 Jun 28     DOI: https://doi.org/10.3857/roj.2020.00857
                              Supplementary         Cited By 2
roj-2020-00857f1.jpgroj-2020-00857f2.jpg
Current approaches in intensification of long-course chemoradiotherapy in locally advanced rectal cancer: a review
Peiman Haddad, Reza Ghalehtaki, Arefeh Saeedian, Farshid Farhan, Mohammad Babaei, Mahdi Aghili
Radiat Oncol J. 2021;39(2):83-90.   Published online 2021 Jun 25     DOI: https://doi.org/10.3857/roj.2021.00108
                                 Cited By 3
Systemic therapy augmented by radiotherapy (STAR) effect for brain metastases in a BRAF-mutated melanoma patient with prolonged survival: a case report
Agostino Cristaudo, Antonio Malorgio, Serena Medoro, Antonio Stefanelli
Radiat Oncol J. 2021;39(1):78-81.   Published online 2021 Mar 3     DOI: https://doi.org/10.3857/roj.2020.00724
                                 Cited By 1
roj-2020-00724f1.jpgroj-2020-00724f2.jpgroj-2020-00724f3.jpg
Biology Contributions
Radioprotective potential of Costus afer against the radiation-induced hematological and histopathological damage in mice
Idowu Richard Akomolafe, Naven Chetty
Radiat Oncol J. 2021;39(1):61-71.   Published online 2021 Mar 26     DOI: https://doi.org/10.3857/roj.2021.00017
                                 Cited By 1
roj-2021-00017f1.jpgroj-2021-00017f2.jpgt1-roj-2021-00017.pngt2-roj-2021-00017.png
Exploring the differentially expressed genes in human lymphocytes upon response to ionizing radiation: a network biology approach
Tamizh Selvan Gnana Sekaran, Vishakh R. Kedilaya, Suchetha N. Kumari, Praveenkumar Shetty, Pavan Gollapalli
Radiat Oncol J. 2021;39(1):48-60.   Published online 2021 Mar 24     DOI: https://doi.org/10.3857/roj.2021.00045
                              Supplementary         Cited By 3
roj-2021-00045f1.jpgroj-2021-00045f2.jpgroj-2021-00045f3.jpgroj-2021-00045f4.jpgroj-2021-00045f5.jpg
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
HDX Corporation
Elekta Korea
Editorial Office
Department of Radiation Oncology, Seoul National University Hospital,
Hamchun Hall, 6F, 95 Daehak-ro, Jongno-gu, Seoul 03082, Republic of Korea
Tel : +82-2-743-6574
E-mail: roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next